Garry L. Jennings mainly focuses on Internal medicine, Endocrinology, Blood pressure, Sympathetic nervous system and Norepinephrine. The Internal medicine study combines topics in areas such as Surgery and Cardiology. His Blood pressure study combines topics in areas such as Circulatory system, Physical exercise and Aorta.
The various areas that Garry L. Jennings examines in his Sympathetic nervous system study include Norepinephrine, Epinephrine, Kidney metabolism, Essential hypertension and Autonomic nervous system. The concepts of his Norepinephrine study are interwoven with issues in Anesthesia and Obesity. His Norepinephrine research includes themes of Pathogenesis, Blood plasma, Electrical conduction system of the heart, Norepinephrine uptake and Angiotensin II.
His main research concerns Internal medicine, Endocrinology, Blood pressure, Cardiology and Sympathetic nervous system. His study in Internal medicine focuses on Hemodynamics, Heart failure, Essential hypertension, Norepinephrine and Heart rate. His Endocrinology study focuses mostly on Catecholamine, Vasodilation, Vascular resistance, Central nervous system and Neurotransmitter.
Garry L. Jennings combines subjects such as Anesthesia, Randomized controlled trial, Surgery and Physical therapy with his study of Blood pressure. His research is interdisciplinary, bridging the disciplines of Left ventricular hypertrophy and Cardiology. His Sympathetic nervous system research is multidisciplinary, incorporating elements of Norepinephrine, Epinephrine, Pathophysiology, Autonomic nervous system and Kidney.
His primary areas of investigation include Internal medicine, Blood pressure, Disease, Public health and MEDLINE. Garry L. Jennings interconnects Endocrinology and Cardiology in the investigation of issues within Internal medicine. His Blood pressure study combines topics from a wide range of disciplines, such as Obesity, Proportional hazards model, Surgery, Stroke and Risk factor.
His Disease research incorporates themes from Diabetes mellitus, Angiotensin-converting enzyme, Virology and Pneumonia. His work carried out in the field of Public health brings together such families of science as Health care, Gerontology and Chronic disease. In his research on the topic of MEDLINE, Heart failure, Disease management and Case fatality rate is strongly related with Intensive care medicine.
His scientific interests lie mostly in Blood pressure, Internal medicine, Public health, Obesity and MEDLINE. His Blood pressure study also includes fields such as
His work deals with themes such as Coronary artery disease and Acute coronary syndrome, which intersect with Endocrinology. His Public health research focuses on Gerontology and how it connects with Promotion, Chronic disease and Depression. As a part of the same scientific study, Garry L. Jennings usually deals with the Obesity, concentrating on Global health and frequently concerns with Young adult, Underweight, Childhood obesity and Body mass index.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults
Leandra Abarca-Gómez;Ziad A Abdeen;Zargar Abdul Hamid;Niveen M Abu-Rmeileh.
The Lancet (2017)
A Comparison of Outcomes With Angiotensin-Converting--Enzyme Inhibitors and Diuretics for Hypertension in the Elderly
Lindon M H Wing;Christopher M Reid;Philip Ryan;Lawrence J Beilin.
The New England Journal of Medicine (2003)
Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity.
Gregory J. Hasking;Murray D. Esler;Garry L. Jennings;Deborah Burton.
Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions
M Esler;G Jennings;G Lambert;I Meredith.
Physiological Reviews (1990)
Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover.
M Esler;G Jennings;P Korner;I Willett.
Pet ownership and risk factors for cardiovascular disease.
Warwick P Anderson;Christopher M Reid;Garry L Jennings.
The Medical Journal of Australia (1992)
Adverse consequences of high sympathetic nervous activity in the failing human heart
David M. Kaye;Jeffrey Lefkovits;Garry L. Jennings;Peter Bergin.
Journal of the American College of Cardiology (1995)
Effect of sunlight and season on serotonin turnover in the brain
GW Lambert;C Reid;DM Kaye;GL Jennings.
The Lancet (2002)
Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension
Kathryn E Ferrier;Michael H Muhlmann;Jean Philippe Baguet;James D Cameron.
Journal of the American College of Cardiology (2002)
DIFFERENCES BETWEEN PATHOLOGICAL AND PHYSIOLOGICAL CARDIAC HYPERTROPHY: NOVEL THERAPEUTIC STRATEGIES TO TREAT HEART FAILURE
Julie R McMullen;Garry L Jennings.
Clinical and Experimental Pharmacology and Physiology (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: